HUB Investment Partners’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$707K Buy
14,756
+4,530
+44% +$195K 0.01% 567
2026
Q1
$376K Sell
10,226
-138
-1% -$6.54K 0.01% 693
2025
Q4
$527K Sell
10,364
-2,710
-21% -$139K 0.01% 473
2025
Q3
$725K Sell
13,074
-5,498
-30% -$322K 0.02% 327
2025
Q2
$1.28M Sell
18,572
-61,876
-77% -$4.21M 0.04% 237
2025
Q1
$5.59M Buy
80,448
+16,780
+26% +$1.39M 0.22% 102
2024
Q4
$5.48M Buy
63,668
+1,847
+3% +$200K 0.23% 102
2024
Q3
$7.36M Buy
61,821
+6,205
+11% +$828K 0.32% 80
2024
Q2
$7.94M Buy
55,616
+4,643
+9% +$615K 0.3% 69
2024
Q1
$6.54M Buy
50,973
+45,338
+805% +$5.4M 0.36% 71
2023
Q4
$583K Buy
5,635
+2,218
+65% +$219K 0.04% 219
2023
Q3
$311K Buy
+3,417
New +$301K 0.05% 187
2023
Q2
Sell
-2,532
Closed -$202K 263
2023
Q1
$202K Buy
+2,532
New +$180K 0.04% 210
2022
Q3
Sell
-3,668
Closed -$204K 188
2022
Q2
$204K Buy
3,668
+4
+0.1% +$222 0.06% 158
2022
Q1
$203K Hold
3,664
0.05% 174
2021
Q4
$205K Buy
+3,664
New +$198K 0.05% 191

Other funds holding NVO

HUB Investment Partners's NVO Position: Q2 2026 in Review

HUB Investment Partners increased its Novo Nordisk (NVO) stake by 44% in Q2 2026, buying an estimated $195K and bringing the position to 14,756 shares worth $707K. The position accounts for 0.01% of the portfolio, ranked #567.

HUB Investment Partners first reported a position in NVO in Q4 2021 and has held it in 16 quarters since. The position peaked at $7.94M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • HUB Investment Partners held 14,756 shares of Novo Nordisk worth $707K as of Q2 2026.
  • HUB Investment Partners bought 4,530 Novo Nordisk shares in Q2 2026, an estimated $195K.
  • Novo Nordisk made up 0.01% of HUB Investment Partners's portfolio in Q2 2026, its #567 holding.
  • HUB Investment Partners first reported a position in Novo Nordisk in Q4 2021 and has held it in 16 quarters since.
  • HUB Investment Partners's Novo Nordisk position peaked at $7.94M in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on HUB Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.